AAV1.NT-3 Gene Therapy for Charcot–Marie–Tooth Neuropathy

Charcot–Marie–Tooth (CMT) neuropathies represent a heterogeneous group of peripheral nerve disorders affecting 1 in 2,500 persons. One variant, CMT1A, is a primary Schwann cell (SC) disorder, and represents the single most common variant. In previous studies, we showed that neurotrophin-3 (NT-3) imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahenk, Zarife, Galloway, Gloria, Clark, Kelly Reed, Malik, Vinod, Rodino-Klapac, Louise R, Kaspar, Brian K., Chen, Lei, Braganza, Cilwyn, Montgomery, Chrystal, Mendell, Jerry R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944324/
https://www.ncbi.nlm.nih.gov/pubmed/24162799
http://dx.doi.org/10.1038/mt.2013.250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944324/
https://www.ncbi.nlm.nih.gov/pubmed/24162799
http://dx.doi.org/10.1038/mt.2013.250

Ejemplares similares